Rydex Biotechnology Fund Class C (RYCFX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
39.70
+0.16 (0.40%)
Jun 18, 2025, 4:00 PM EDT
RYCFX Holdings List
As of May 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 7.26% |
2 | AMGN | Amgen Inc. | 4.84% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 4.60% |
4 | GILD | Gilead Sciences, Inc. | 4.55% |
5 | REGN | Regeneron Pharmaceuticals, Inc. | 3.58% |
6 | CTVA | Corteva, Inc. | 3.18% |
7 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.83% |
8 | ONC | BeOne Medicines Ltd. | 2.35% |
9 | FGXXX | First American Government Obligations Fund | 2.24% |
10 | AZN | AstraZeneca PLC | 2.19% |
11 | NTRA | Natera, Inc. | 2.18% |
12 | RPRX | Royalty Pharma plc | 1.92% |
13 | BIIB | Biogen Inc. | 1.86% |
14 | UTHR | United Therapeutics Corporation | 1.76% |
15 | INSM | Insmed Incorporated | 1.67% |
16 | ILMN | Illumina, Inc. | 1.59% |
17 | EXEL | Exelixis, Inc. | 1.57% |
18 | BMRN | BioMarin Pharmaceutical Inc. | 1.55% |
19 | NBIX | Neurocrine Biosciences, Inc. | 1.53% |
20 | ARGX | argenx SE | 1.48% |
21 | EXAS | Exact Sciences Corporation | 1.47% |
22 | VTRS | Viatris Inc. | 1.44% |
23 | INCY | Incyte Corporation | 1.42% |
24 | MRNA | Moderna, Inc. | 1.33% |
25 | TGTX | TG Therapeutics, Inc. | 1.30% |
26 | HALO | Halozyme Therapeutics, Inc. | 1.30% |
27 | BBIO | BridgeBio Pharma, Inc. | 1.29% |
28 | RVMD | Revolution Medicines, Inc. | 1.27% |
29 | BNTX | BioNTech SE | 1.27% |
30 | GH | Guardant Health, Inc. | 1.26% |
31 | ADMA | ADMA Biologics, Inc. | 1.23% |
32 | LEGN | Legend Biotech Corporation | 1.16% |
33 | JAZZ | Jazz Pharmaceuticals plc | 1.13% |
34 | BPMC | Blueprint Medicines Corporation | 1.13% |
35 | ROIV | Roivant Sciences Ltd. | 1.11% |
36 | ALKS | Alkermes plc | 1.06% |
37 | CYTK | Cytokinetics, Incorporated | 1.06% |
38 | CRSP | CRISPR Therapeutics AG | 1.04% |
39 | MEDP | Medpace Holdings, Inc. | 1.03% |
40 | IONS | Ionis Pharmaceuticals, Inc. | 0.99% |
41 | AXSM | Axsome Therapeutics, Inc. | 0.91% |
42 | SRPT | Sarepta Therapeutics, Inc. | 0.91% |
43 | RNA | Avidity Biosciences, Inc. | 0.88% |
44 | RARE | Ultragenyx Pharmaceutical Inc. | 0.87% |
45 | SMMT | Summit Therapeutics Inc. | 0.85% |
46 | SWTX | SpringWorks Therapeutics, Inc. | 0.84% |
47 | VKTX | Viking Therapeutics, Inc. | 0.82% |
48 | PTCT | PTC Therapeutics, Inc. | 0.81% |
49 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.80% |
50 | VCYT | Veracyte, Inc. | 0.73% |
51 | DNLI | Denali Therapeutics Inc. | 0.72% |
52 | PTGX | Protagonist Therapeutics, Inc. | 0.71% |
53 | ASND | Ascendis Pharma A/S | 0.71% |
54 | PCVX | Vaxcyte, Inc. | 0.70% |
55 | ACLX | Arcellx, Inc. | 0.69% |
56 | RXRX | Recursion Pharmaceuticals, Inc. | 0.67% |
57 | FOLD | Amicus Therapeutics, Inc. | 0.67% |
58 | TWST | Twist Bioscience Corporation | 0.65% |
59 | IDYA | IDEAYA Biosciences, Inc. | 0.64% |
60 | NUVL | Nuvalent, Inc. | 0.63% |
61 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.61% |
62 | APLS | Apellis Pharmaceuticals, Inc. | 0.60% |
63 | ACAD | ACADIA Pharmaceuticals Inc. | 0.59% |
64 | BEAM | Beam Therapeutics Inc. | 0.59% |
65 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.58% |
66 | AGIO | Agios Pharmaceuticals, Inc. | 0.57% |
67 | CLDX | Celldex Therapeutics, Inc. | 0.53% |
68 | DVAX | Dynavax Technologies Corporation | 0.53% |
69 | KRYS | Krystal Biotech, Inc. | 0.50% |
70 | IOVA | Iovance Biotherapeutics, Inc. | 0.50% |
71 | DYN | Dyne Therapeutics, Inc. | 0.50% |
72 | IMVT | Immunovant, Inc. | 0.47% |
73 | NVAX | Novavax, Inc. | 0.44% |
74 | NTLA | Intellia Therapeutics, Inc. | 0.43% |
75 | GERN | Geron Corporation | 0.26% |
76 | n/a | J.P. Morgan Securities Llc | 0.23% |
77 | n/a | Barclays Capital, Inc. | 0.10% |
78 | n/a | Bofa Securities, Inc. | 0.09% |
79 | n/a | Other Assets & Liabilities | -2.36% |
As of May 31, 2025